These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1724020)

  • 1. Binding inhibitors restore furosemide potency in tubule fluid containing albumin.
    Kirchner KA; Voelker JR; Brater DC
    Kidney Int; 1991 Sep; 40(3):418-24. PubMed ID: 1724020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratubular albumin blunts the response to furosemide-A mechanism for diuretic resistance in the nephrotic syndrome.
    Kirchner KA; Voelker JR; Brater DC
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1097-101. PubMed ID: 2319462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
    Voelker JR; Jameson DM; Brater DC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):772-8. PubMed ID: 2778714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
    Agarwal R; Gorski JC; Sundblad K; Brater DC
    J Am Soc Nephrol; 2000 Jun; 11(6):1100-1105. PubMed ID: 10820174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats.
    Kirchner KA; Voelker JR; Brater DC
    J Am Soc Nephrol; 1992 Jan; 2(7):1201-7. PubMed ID: 1591361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
    Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
    Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin antagonizes furosemide's intratubular effects during loop segment microperfusion.
    Kirchner KA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):881-6. PubMed ID: 3480354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?
    Akcicek F; Yalniz T; Basci A; Ok E; Mees EJ
    BMJ; 1995 Jan; 310(6973):162-3. PubMed ID: 7833755
    [No Abstract]   [Full Text] [Related]  

  • 9. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?
    Na KY; Han JS; Kim YS; Ahn C; Kim S; Lee JS; Bae KS; Jang IJ; Shin SG; Huh W; Jeon US
    J Korean Med Sci; 2001 Aug; 16(4):448-54. PubMed ID: 11511790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of drug binding sites on mammalian albumins.
    Panjehshahin MR; Yates MS; Bowmer CJ
    Biochem Pharmacol; 1992 Sep; 44(5):873-9. PubMed ID: 1382424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome.
    Haws RM; Baum M
    Pediatrics; 1993 Jun; 91(6):1142-6. PubMed ID: 8502517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug binding sites on chicken albumin: a comparison to human albumin.
    Rajaian H; Symonds HW; Bowmer CJ
    J Vet Pharmacol Ther; 1997 Dec; 20(6):421-6. PubMed ID: 9430764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The displacement of bilirubin from albumin by furosemide.
    Shankaran S; Poland RL
    J Pediatr; 1977 Apr; 90(4):642-6. PubMed ID: 839387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of furosemide delivery to its site of action.
    Sjöström PA; Kron BG; Odlind BG
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S38-41. PubMed ID: 7781204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term modulation of distal tubule fluid nitric oxide in vivo by loop NaCl reabsorption.
    Levine DZ; Burns KD; Jaffey J; Iacovitti M
    Kidney Int; 2004 Jan; 65(1):184-9. PubMed ID: 14675049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide binding to human albumin and plasma of nephrotic children.
    Prandota J; Pruitt AW
    Clin Pharmacol Ther; 1975 Feb; 17(2):159-65. PubMed ID: 235396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ; Spencer AP; Eisele G
    Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and diuretic effect of furosemide in the nephrotic syndrome.
    Keller E; Hoppe-Seyler G; Schollmeyer P
    Clin Pharmacol Ther; 1982 Oct; 32(4):442-9. PubMed ID: 7116760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diuretic drugs on Na, Cl, and K transport by rat renal distal tubule.
    Velázquez H; Wright FS
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1013-23. PubMed ID: 3717344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.